Objects – assortment medicines for pharmacotherapy of chronic prostatitis, their pharmacoeconomic аnd information valuation and using, outpatients of chronic prostatitis, urologists; aim – scientific and practical design of model concept of pharmaceutical care for patients with chronic prostatitis by results marketing аnd the clinical and economic researching; methods – system, observation, comparison, analysis, synthesis, information search, mathematical statistics, «cost/effectiveness», frequency, integrated АВС/FMR/VED-analysis, АТС/DDD methodology, expert assessments, modeling, generalization; novelty –the first time: by analyzing with using renewal coefficient assortment list on/off of prostate protectors to/from State Formulary of Medicines of the first-ninth issues that testified the stabilization of the range of assortment State Formulary of Medicines of the eighth and ninth issues on background previous annual abbreviation; the research of instructions for medical using of registered of trade names of Тamsulosin, that allows safety, rationality, controllability аnd individualization pharmacotherapy of chronic prostatitis as a result consideration of some discrepancies in interpretation features using these trade names; conducted statistical аnd pharmacoeconomic assessment of clinical analysis of drugs for therapy of chronic prostatitis, that pointed at the clinical and economic advantage for therapy of chronic prostatitis by 5 medicines; researched condition appointment/realization drugs for patients with chronic prostatitis in terms outpatient facilities Health Care аnd pharmacy, which made it possible their allocation by АТХ-classification, value, frequency appointment/realization units of dose аnd availability State Formulary of Medicines; processed concept pharmaceutical care for patients with chronic prostatitis, which modeled on the Ishikawa diagram, that permit reveal and group factors, which influence on case pharmaceutical care for patients with chronic prostatitis, and analyze causal communication in this process; successive development acquired research assortment of prostate protectors that here registered in Ukraine, which, unlike available, committed compared with Poland and Republic Belarus of structure of their manufacturers and applicants, contractual forms of commercial distribution, assortment dependence on imports and type of dosage form; results - significantly supplemented main directions pharmaceutical care for patients with chronic prostatitis in Health Care of Ukraine, processed proposal and recommendations, that promote rise quality pharmaceutical care for patients with chronic prostatitis, preparedand agreed by Academic Council Ivano-Frankivsk National Medical University two scientific and methodical recommendations «Information support rational pharmacotherapy prostatitis tamsulosin» and «Integrated ABC/FMR/VED–analysis return of prostate protectors in Health Care facility»; introduced – into practical work medical and pharmaceutical organizations regional and local level and scientific and educational process institutions of higher educational pharmaceutical profile; branch – pharmacy.
